SCHEMBL21215828

SCHEMBL21215828

c1ccc(-c2ccc3ccc4ccc(-c5cc(-c6ccc7cc8ccccc8cc7n6)cc(-c6ccc7cc8ccccc8cc7n6)c5)nc4c3n2)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.44
▸ LMNA P02545 5/20 0.44
▸ NPC1 O15118 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ RAB9A P51151 4/20 0.44
▸ PKM P14618 3/20 0.44
▸ MAPT P10636 2/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ TP53 P04637 3/20 0.43
▸ CCR1 P32246 3/20 0.43
▸ CCR5 P51681 3/20 0.43
▸ CCR8 P51685 3/20 0.43
▸ ALOX15 P16050 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ ALPL P05186 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ ALPI P09923 1/20 0.43
▸ ALPG P10696 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21215907 0.94 KDM4E (0.45) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215625 0.93 KDM4E (0.44) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215958 0.92 KDM4E (0.43) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215624 0.91 KDM4E (0.55) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215882 0.91 KDM4E (0.55) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215775 0.91 KDM4E (0.42) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215590 0.90 KDM4E (0.50) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215742 0.88 CCR1 (0.48) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215584 0.88 CCR1 (0.48) KDM4ELMNANPC1SMN1; SMN2RAB9A
SCHEMBL21215581 0.86 NPC1 (0.45) KDM4ELMNANPC1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190233398-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2019-08-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190233398-A1 HETEROCYCLIC COMPOUND, AND ORGANIC LIGHT-EMITTING DEVICE USING SAME CRY1, CRY2, PER2 KDM4E 2382/4885LMNA 781/4885NPC1 4195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback